Global transcriptome and sequenome analysis of formalin-fixed salivary epithelial-myoepithelial carcinoma specimens

Genes Chromosomes and Cancer

Volumn 54, Issue 4, 2015, Pages 249-259

  Fonseca, Isabel ^a,b   Bell, Achim ^c   Wani, Khalida ^d   Bell, Diana ^d  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c LONE STAR COLLEGE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; GENOMIC DNA; MICRORNA; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE CATALYTIC SUBUNIT; RNA; SCATTER FACTOR RECEPTOR; SEQUENOME; TRANSCRIPTOME; TUMOR MARKER; UNCLASSIFIED DRUG; FIXATIVE; FORMALDEHYDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MIDDLE AGED; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RNA SEQUENCE; SALIVARY EPITHELIAL MYOEPITHELIAL CARCINOMA; SALIVARY GLAND CARCINOMA; UPREGULATION; VERY ELDERLY; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; MYOEPITHELIOMA; PATHOLOGY; SALIVARY GLAND TUMOR; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIXATIVES; FORMALDEHYDE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; MYOEPITHELIOMA; SALIVARY GLAND NEOPLASMS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84923124570     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22238     Document Type: Article

References (32)

1. Azuma K, Kawahara A, Sonoda K, Nakashima K, Tashiro K, Watari K, Izumi H, Kage M, Kuwano M, Ono M, Hoshino T. 2014. FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor. Oncotarget 5:5908-5919.
2. Baker AR, Ohanessian SE, Adil E, Crist HS, Goldenberg D, Mani H. 2013. Dedifferentiated epithelial-myoepithelial carcinoma: Analysis of a rare entity based on a case report and literature review. Int J Surg Pathol 21:514-519.
3. Balz LM, Bartkowiak K, Andreas A, Pantel K, Niggemann B, Zanker KS, Brandt BH, Dittmar T. 2012. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-gamma1 signalling in breast cancer cell migration and dissemination. J Pathol 227:234-244.
4. Blouin JM, Penot G, Collinet M, Nacfer M, Forest C, Laurent-Puig P, Coumoul X, Barouki R, Benelli C, Bortoli S. 2011. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex. Int J Cancer 128:2591-2601.
5. Bretschneider N, Brand H, Miller N, Lowery AJ, Kerin MJ, Gannon F, Denger S. 2008. Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner. Cancer Res 68:106-114.
6. Brocheriou C, Auriol M, de Roquancourt A, Gaulard P, Fornes P. 1991. [Epithelial-myoepithelial carcinoma of the salivary glands. Study of 15 cases and review of the literature]. Ann Pathol 11:316-325.
7. Chiosea SI, Miller M, Seethala RR. 2014. HRAS mutations in epithelial-myoepithelial carcinoma. Head Neck Pathol 8:146-150.
8. Cros J, Sbidian E, Hans S, Roussel H, Scotte F, Tartour E, Brasnu D, Laurent-Puig P, Bruneval P, Blons H, Badoual C. 2013. Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. Ann Oncol 24:2624-2629.
9. Donath K, Seifert G, Schmitz R. 1972. [Diagnosis and ultrastructure of the tubular carcinoma of salivary gland ducts. Epithelial-myoepithelial carcinoma of the intercalated ducts]. Virchows Arch A Pathol Pathol Anat 356:16-31.
10. Egland KA, Vincent JJ, Strausberg R, Lee B, Pastan I. 2003. Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins. Proc Natl Acad Sci USA 100:1099-1104.
11. Freier K, Schwaenen C, Sticht C, Flechtenmacher C, Muhling J, Hofele C, Radlwimmer B, Lichter P, Joos S. 2007. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Oral Oncol 43:60-66.
12. Horvath A, Pakala SB, Mudvari P, Reddy SD, Ohshiro K, Casimiro S, Pires R, Fuqua SA, Toi M, Costa L, Nair SS, Sukumar S, Kumar R. 2013. Novel insights into breast cancer genetic variance through RNA sequencing. Sci Rep 3:2256.
13. Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, Lin L. 2013. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2). J Biol Chem 288:10973-10985.
14. Jiao L, Deng Z, Xu C, Yu Y, Li Y, Yang C, Chen J, Liu Z, Huang G, Li LC, Sun Y. 2014. miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence. J Cell Physiol 229:834-844.
15. Kato T, Ito T, Imatani T, Minaguchi K, Saitoh E, Okuda K. 2004. Cystatin SA, a cysteine proteinase inhibitor, induces interferon-gamma expression in CD4-positive T cells. Biol Chem 385:419-422.
16. Kim YW, Kim EY, Jeon D, Liu JL, Kim HS, Choi JW, Ahn WS. 2014. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. Drug Des Dev Ther 8:293-314.
17. Li B, Dewey CN. 2011. RSEM: Accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf 12:323.
18. Li B, Ruotti V, Stewart RM, Thomson JA, Dewey CN. 2010. RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics 26:493-500.
19. Long Q, Xu J, Osunkoya AO, Sannigrahi S, Johnson BA, Zhou W, Gillespie T, Park JY, Nam RK, Sugar L, Stanimirovic A, Seth AK, Petros JA, Moreno CS. 2014. Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Res 74:3228-3237.
20. Marco A, Macpherson JI, Ronshaugen M, Griffiths-Jones S. 2012. MicroRNAs from the same precursor have different targeting properties. Silence 3:8.
21. Meiri E, Levy A, Benjamin H, Ben-David M, Cohen L, Dov A, Dromi N, Elyakim E, Yerushalmi N, Zion O, Lithwich-Yanai G, Sitbon E. 2010. Discovery of microRNAs and other small RNAs in solid tumors. Nucl Acids Res 38:6234-6246.
22. Murase H, Inokuchi M, Takagi Y, Kato K, Kojima K, Sugihara K. 2014. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer. Mol Clin Oncol 2:509-517.
23. Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z, Ran Y. 2010. Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 24:105-112.
24. Prior IA, Lewis PD, Mattos C. 2012. A comprehensive survey of Ras mutations in cancer. Cancer Res 72:2457-2467.
25. Rehrauer H, Opitz L, Tan G, Sieverling L, Schlapbach R. 2013. Blind spots of quantitative RNA-seq: The limits for assessing abundance, differential expression, and isoform switching. BMC Bioinf 14:370.
26. Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F, Signoroni S, Costa A, Leo E, Pilotti S, Pierotti MA. 2009. Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes Chromosomes Cancer 48:953-962.
27. Seethala RR, Barnes EL, Hunt JL. 2007. Epithelial-myoepithelial carcinoma: A review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol 31:44-57.
28. Tralongo V, Daniele E. 1998. Epithelial-myoepithelial carcinoma of the salivary glands: a review of literature. Anticancer Res 18:603-608.
29. Uhlmann S, Zhang JD, Schwager A, Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U, Wiemann S, Sahin O. 2010. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29:4297-4306.
30. Wang Z, Gerstein M, Snyder M. 2009. RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet 10:57-63.
31. Wolf JB. 2013. Principles of transcriptome analysis and gene expression quantification: An RNA-seq tutorial. Mol Ecol Resour 13:559-572.
32. Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, Yun JP. 2012. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 31:4421-4433.